HiQō Clinical Intelligence - Logic-Driven Mental Health Decision Support.

HiQō is the advanced clinical intelligence engine behind the HiBoop platform. It uses deterministic logic and pattern recognition to provide real-time clinical oversight, risk assessment, and comorbidity mapping for mental health assessments.

HiQō implements DSM-5-TR and ICD-11 diagnostic criteria for supported assessments to support clinicians in making data-informed decisions. Our engine surfaces patterns that traditional assessment scoring often misses, enhancing the quality of care and patient outcomes. By using validated clinical algorithms, HiQō identifies shifts in patient trajectories, providing technical signals for clinical deterioration or treatment response. This intelligence layer transforms raw assessment data into direct clinical signals, enabling healthcare teams to deliver proactive mental health care across the system.

if (symptom.severity > threshold) {
return assessmentScore.calculate();
const pattern = detectComorbidity()
// DSM-5-TR diagnostic logic
model.predict(riskTrajectory)
function analyzePopulation() {
const correlation = 0.87;
clinicalIntelligence.process()
}
Introducing HiQō

The clinical brain
behind HiBoop.

HiQō is the intelligence engine powering Active Continuity. Pattern detection, risk trajectories, and DSM-5-TR diagnostic logic for validated mental health assessments.
Validated tools
DSM-5-TR
Aligned
Algorithmic Scoring
Primary Differentiators

Not just scoring.
Clinical reasoning.

Most platforms stop at auto-scoring. HiQō detects patterns, tracks symptom trajectories, and surfaces insights that would take humans hours to find.

DSM-5-TR Diagnostic Logic

Implements diagnostic criteria and severity specifiers for supported assessments. Real-time clinical reasoning, not just cutoff scores.

Risk Assessment & Monitoring

Tracks symptom patterns over time to identify trajectories and alert clinicians to significant changes in patient status.

Comorbidity Mapping

Automatically identifies relationships between co-occurring conditions. Visualize how anxiety, trauma, and substance use cluster.

Population Analytics

Identifies correlations and trends across your entire patient population. Track symptom trajectories and quantify treatment efficacy.

Foundational Science

Built on
peer-reviewed science.

HiQō implements diagnostic criteria and clinical guidelines from leading medical organizations. Every algorithm is traceable to published research.

Ref 01

DSM-5-TR

Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (APA, 2022)

ORG: Amer Psych Assoc
Ref 02

ICD-11

International Classification of Diseases, 11th Revision (WHO, 2022)

ORG: World Health Org
Ref 03

SAMHSA

Substance Abuse and Mental Health Services Administration clinical guidelines

ORG: US Dept HHS
Technical Architecture

Built for clinical precision.
Evidence-based intelligence.

HiQō combines validated clinical algorithms with intelligent pattern recognition to provide assessment scoring, severity classification, and longitudinal tracking that helps clinicians identify trends and improve treatment.

HIPAA-Compliant Infrastructure

Clinical data is encrypted at rest (AES-256) and in transit (TLS 1.3). PHI is access-controlled under BAA. Processing occurs on our secure, HIPAA-compliant cloud.

Version-Controlled Clinical Logic

Every diagnostic criterion, severity threshold, and scoring rule is version-controlled and traceable. Full audit trail for regulatory compliance.

Continuous Clinical Refinement

Regular updates incorporate the latest clinical research and diagnostic criteria revisions, ensuring HiQō stays aligned with evolving best practices.

hiboop-cli v2.0.1
Active Continuity Heuristic

Adaptive algorithms for symptom pattern detection.

HiQō's diagnostic logic uses transparent, evidence-based branching protocols to identify comorbidities that often remain undetected in single-point assessments.

Platform Features
Collaborative Care Model // SBIRT Protocol
01
Intake_Node
Broad Clinical Screener
02
Trigger_Logic
Comorbidity Threshold Reached
03
Escalation_Node
Trigger: PCL-5 (Trauma)
Developer API - Coming Q2 2026

Build on the clinical intelligence
you can't build yourself.

We're opening HiQō to developers. Integrate our clinical intelligence engine into your EHR, research platform, or custom clinical workflow. REST API, webhooks, real-time scoring, and pattern detection, available as a service.

RESTful API

Simple HTTP endpoints for assessment scoring, symptom tracking, and population analytics. Full OpenAPI documentation.

Webhook Events

Real-time notifications for critical clinical events, risk threshold changes, and population trend alerts.

SDKs & Libraries

Official client libraries for Python, JavaScript, and .NET. Typescript types, complete examples, and starter kits.

SOC 2 Ready Infrastructure

OAuth 2.0 authentication, encrypted data in transit and at rest, SOC 2 ready infrastructure, and BAA included.

Request Early Access

Join the waitlist for developer API access. We're granting early access to select partners building the next generation of clinical tools.

Request API Access
The Competitive Edge

Everyone has forms.
No one has this.

Capability
HiBoop + HiQō
Other Platforms
Automated scoring
DSM-5-TR diagnostic criteria implementation
Population pattern detection ML-powered
Longitudinal trend tracking & alerts
Comorbidity constellation mapping
Symptom change tracking over time
Regular clinical updates & refinements

Clinical Evidence Index

Every assessment algorithm in HiQō is traceable to peer-reviewed research. This index provides the primary validation sources for our diagnostic logic.

Depressive Disorders

PHQ-9: Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001.
EPDS: Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987.
BDI-II: Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. Psychological Corporation; 1996.

Anxiety Disorders

GAD-7: Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006.
HAM-A: Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959.
SPIN: Connor KM, et al. Psychometric properties of the Social Phobia Inventory (SPIN). Br J Psychiatry. 2000.

Trauma & Stress

PCL-5: Bovin MJ, Marx BP, et al. Psychometric properties of the PTSD Checklist for DSM-5. Psychol Assess. 2016.
LEC-5: Weathers FW, et al. The Life Events Checklist for DSM-5 (LEC-5). National Center for PTSD. 2013.
ACE: Felitti VJ, et al. Childhood abuse and household dysfunction. Am J Prev Med. 1998.

Substance Use

AUDIT: Saunders JB, et al. Development of the Alcohol Use Disorders Identification Test. Addiction. 1993.
CAGE-AID: Brown RL, Rounds LA. Concomitant screening for problem drinking and drug use. Wis Med J. 1995.
DAST-10: Skinner HA. The drug abuse screening test. Addict Behav. 1982.

Neurodevelopmental

ASRS-v1.1: Kessler RC, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychol Med. 2005.
CAT-Q: Hull L, et al. The Camouflaging Autistic Traits Questionnaire (CAT-Q). J Autism Dev Disord. 2019.

Validation Cycle: Q1 2026 // Source: Pubmed Open Access